NetworkNewsBreaks – Vivos Therapeutics Inc. (NAS
Post# of 51
(Total Views: 367)
Posted On: 03/18/2021 4:06:09 PM
NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Conference Call to Release, Discuss Q4, FY 2020 Financial Results
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), plans to release its fourth-quarter and full-year financial reports on March 25, 2021, after market close; the numbers will cover the period ending Dec. 31, 2020. The company has scheduled a conference call for 5 p.m. ET the same day. During the call, Vivos executives will discuss the financial report and provide an overview of the company’s 2020 milestones and growth strategy moving forward. Interested parties can access the call by dialing (877) 451-6152; international callers can dial (201) 389-0879; the passcode for the call is 13717735. After the call has concluded, a replay of the call can be accessed until April 8, 2021, by dialing (844) 512-2921 — international callers dial (412) 317-6671; the same passcode will be used for the replay. A live webcast version of the call will also be available, with an online archive of the webcast available on the company’s website for 30 days.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), plans to release its fourth-quarter and full-year financial reports on March 25, 2021, after market close; the numbers will cover the period ending Dec. 31, 2020. The company has scheduled a conference call for 5 p.m. ET the same day. During the call, Vivos executives will discuss the financial report and provide an overview of the company’s 2020 milestones and growth strategy moving forward. Interested parties can access the call by dialing (877) 451-6152; international callers can dial (201) 389-0879; the passcode for the call is 13717735. After the call has concluded, a replay of the call can be accessed until April 8, 2021, by dialing (844) 512-2921 — international callers dial (412) 317-6671; the same passcode will be used for the replay. A live webcast version of the call will also be available, with an online archive of the webcast available on the company’s website for 30 days.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Vivos Therapeutics Inc. (VVOS) Stock Research Links
Scroll down for more posts ▼